BCBA/BIOX (BCBA/BIOX)

Buenos Aires Stock Exchange: BCBA/BIOX · ARS

ARS 402

+2.00 (+0.5%)· Recorded snapshot

Market cap	24.3B
Revenue (ttm)	352.3B
Net income (ttm)	-69.5B
EPS (ttm)	-ARS 1,135
Volume	177,253

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 352.3B
Net income (ttm): -69.5B
EPS (ttm): -ARS 1,135
Market cap: 24.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-28.1

P25 n/aP50 n/aP75 n/a

ROIC-0.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/BIOX indicators

Market & fundamental data

Available fields

195

Groups with data

Currency

USD

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Cayman Islands
Country code	AR
Earnings date	2026-11-13
Employees change	362
Employees growth	93.06%
Enterprise value	ARS 408B
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2001
Industry	Agricultural Inputs
Is primary listing	No
ISIN number	ARBCOM4603K3
Last earnings date	2026-09-15
Last refreshed	2026-10-29
Last stock split date	2024-01-24
Last stock split type	Forward
Market cap	ARS 24.3B
Next earnings date	2026-11-13
Price	ARS 402.25
Price currency	ARS
Sector	Materials
SIC code	2870
Stock price date	2026-10-28
Symbol	bcba/BIOX
Website	https://investors.biocerescrops.com/home/default.aspx

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-282.04%
EV/EBITDA	16.41x
EV/FCF	3.34x
EV/Sales	1.12x
FCF / EV yield	29.98%
FCF yield	503.76%
P/(FCF - SBC) ratio	0.2x
P/(OCF - SBC) ratio	0.2x
P/B ratio	0.26x
P/FCF ratio	0.2x
P/OCF ratio	0.19x
P/S ratio	0.07x
Price/EBITDA ratio	1.03x
Sector P/E	13.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-0.21%
EBITDA margin	6.72%
FCF margin	28.74%
Gross margin	34.69%
Operating margin	-0.21%
Pretax margin	-19.76%
Profit margin	-19.72%
ROA	-0.05%
ROA (5Y)	2.51%
ROCE	-0.24%
ROE	-28.05%
ROE (5Y)	-7.8%
ROIC	-0.16%
ROIC (5Y)	2.38%
SBC / revenue	0.74%
Tax / revenue	1.43%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth 3Y	140.54%
Gross profit growth	-44.94%
Gross profit growth (Q)	-45.76%
Gross profit growth 3Y	-22.3%
Gross profit growth 5Y	0.5%
Net income growth quarters	1
Net income growth years	0
OCF growth	1,344.86%
OCF growth 3Y	93.85%
Revenue growth	-37.96%
Revenue growth (Q)	-23.35%
Revenue growth (QoQ)	49.21%
Revenue growth 3Y	-17%
Revenue growth 5Y	6.47%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -3.6B
Depreciation and amortization	ARS 25.3B
EBIT	ARS -740.8M
EBITDA	ARS 23.7B
EPS	ARS -1,134.52
Financing cash flow	ARS -130.9B
Free cash flow	ARS 122.3B
Free cash flow minus SBC	ARS 119.2B
Gross profit	ARS 122.2B
Income taxes	ARS 5B
Investing cash flow	ARS -7.8B
Net borrowing	ARS -105.7B
Net cash flow	ARS -27.9B
Net income	ARS -69.5B
Operating cash flow minus SBC	ARS 122.8B
Operating income	ARS -740.8M
Revenue	ARS 352.3B
Stock-based compensation	ARS 3.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	ARS 910.80
Debt / EBITDA	14.83
Debt / equity	3.69
Debt / FCF	2.87
Goodwill	ARS 55.5B
Interest coverage	-0.01
Long-term assets	ARS 367.1B
Long-term liabilities	ARS 192.5B
Net cash (debt)	ARS -332.7B
Net cash / market cap	-1,370.39%
Net debt / EBITDA	14.07
Net debt / equity	3.5
Net debt / FCF	2.72
Piotroski F-Score	3
Property, plant and equipment	ARS 110.3B
Shareholders' equity	ARS 95B
Tangible book value	ARS -117.3B
Tangible book value per share	ARS -1,844.89
Total assets	ARS 698.2B
Total cash	ARS 18.1B
Total debt	ARS 350.8B
Total liabilities	ARS 603.3B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.39
Current assets	ARS 331.1B
Current liabilities	ARS 410.8B
Current ratio	0.81
Inventory turnover	2.27
Net working capital	ARS 154.1B
Quick ratio	0.46
Working capital	ARS -76.7B
Working capital turnover	-8,648.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.27%
Shareholder yield	-1.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 628.77
1D price change	0.5%
1M price change	-31.82%
1M total return	-31.82%
1W price change	-4.57%
1W total return	-4.57%
1Y price change	-86.33%
1Y return CAGR	-86.35%
1Y total return	-86.33%
20-day SMA	ARS 487.59
200-day SMA	ARS 772.89
3M price change	-25.23%
3M total return	-25.23%
3Y price change	-95.65%
3Y return CAGR	-64.83%
3Y total return	-95.65%
50-day SMA	ARS 584.01
50-day SMA vs 200-day SMA	50under200
52-week high	ARS 3,162.50
52-week high date	2025-11-03
52-week low	ARS 362.00
52-week low date	2026-10-27
5Y price change	-84.48%
5Y return CAGR	-31.11%
5Y total return	-84.48%
6M price change	-50.12%
6M total return	-50.12%
All-time high	ARS 18,250.00
All-time high date	2024-01-22
All-time low	ARS 362.00
All-time low date	2026-10-27
Average true range (ATR)	ARS 43.10
Average volume	108.8K
Change from 52-week high	-87.28%
Change from 52-week low	11.12%
Change from all-time high	-97.8%
Change from all-time low	11.12%
Change from open	4.14%
Day's gap	-3.5%
Dollar volume	ARS 71.3M
High price	ARS 409.00
Low price	ARS 386.25
Monthly RSI	31.03
Open price	ARS 386.25
Position in 52-week range	70.33%
Previous close	ARS 400.25
Price vs 150-day SMA	-36.03%
Price vs 20-day SMA	-17.5%
Price vs 200-day SMA	-47.96%
Price vs 50-day SMA	-31.12%
Relative volume	1.63
RSI	26.96
Sharpe ratio	-1.95
Sharpe ratio (3Y)	-1.2
Sharpe ratio (5Y)	-0.33
Sortino ratio	-2.54
Sortino ratio (3Y)	-1.62
Sortino ratio (5Y)	-0.39
Volume	177.3K
Weekly RSI	27.63
YTD price change	-80.05%
YTD total return	-80.05%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44.9M
Shares change (QoQ)	0%
Shares change (YoY)	1.27%
Shares held by insiders	1.31%
Shares held by institutions	6.3%
Short ratio	2.8 days

Deeper analysis on BCBA/BIOX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/BIOX report

Is a complete BCBA/BIOX research report available?

No complete published report is available for bcba/BIOX (BCBA/BIOX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/BIOX (BCBA/BIOX)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/BIOX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/BIOX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/BIOX

Frequently asked questions